Document:

Employment Agreement dated as of August 13, 2004 - Thomas A. Armer

 EXHIBIT 10.7 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made the 13th
day of August, 2004 (the “Effective Date”), by and between MAP PHARMACEUTICALS, INC., a Delaware corporation (“MAP”), and Thomas A. Armer, Ph.D, an individual resident of California (the
“Executive”). Capitalized terms not otherwise defined in this Agreement shall have the meanings given in Appendix A to this Agreement. 
 RECITALS: 
 WHEREAS, the Executive is currently employed by MAP pursuant to the terms of that certain
Employment Agreement between MAP and the Executive dated December 18, 2003 (the “Current Agreement”); 
 WHEREAS, MAP
desires to secure the Executive’s continued employment with MAP on the terms and conditions hereinafter set forth; 
 WHEREAS, the
Executive desires to continue his employment on the terms and conditions hereinafter set forth. 
 NOW, THEREFORE, in consideration of the
Executive’s continued employment by MAP and the mutual covenants and agreements hereinafter set forth, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

 1. Employment. 
 (a) The
Current Agreement is hereby terminated and superseded by this Agreement by mutual consent of MAP and the Executive; provided, however, that Sections 6 and 9 thereof shall survive such termination as contemplated by the Current
Agreement. 
 (b) As of the Effective Date, MAP shall employ the Executive, and the Executive shall serve as President and Chief Science
Officer of MAP, until the Board of Directors of MAP (the “Board”) appoints a new President and Chief Executive Officer, after which time the Executive shall serve as Executive Vice President and Chief Science Officer of MAP, and any
other position agreed upon by the parties, subject to the terms and conditions set forth in this Agreement. The Executive shall devote all of his business time, attention, skill and efforts to the performance of his duties under this Agreement,
provided that the Executive may devote reasonable periods of time to charitable and community activities that do not materially interfere with the performance of his duties hereunder and are not in conflict or competitive with, or adverse to,
the interests of MAP. 
 2. Term. The term of this Agreement, and the Executive’s employment under the terms of this Agreement,
shall commence on the Effective Date and continue through July 31, 2005 (the “Initial Term”). This Agreement shall automatically renew for three successive periods of one year each upon expiration of the Initial Term (each, a
“Renewal Term”), unless 

 
either party provides written notice of termination at least three months prior to the end of the Initial Term or the initial Renewal Term and at least one
month prior to the end of any other Renewal Term. (The Initial Term and each Renewal Term are sometimes hereafter collectively referred to as the “Term.”) This Agreement may be terminated prior to the expiration of the Term as provided in
Section 5 and is subject to the ongoing post-employment rights and obligations and benefits, if applicable, due to the circumstance of such termination, contained in Sections 4, 6, 7, 8 and 9. 
 3. Compensation and Benefits. 
 (a)
Base Salary and Bonus. The Executive shall receive a base salary at the rate of $230,000 per annum, commencing on the Effective Date (the “Base Salary”). The Base Salary shall be paid at least monthly in accordance with
MAP’s regular payroll practices. In addition, Executive shall receive a commencement bonus of $50,000 promptly following the Effective Date (in any case not to exceed five (5) days following such date). 
 (b) Health and Retirement Benefits. The Executive shall be entitled to participate in all employee health and retirement benefit plans maintained
by MAP, including, without limitation, any medical, dental, disability and life insurance coverage and retirement benefits maintained by MAP (“MAP Benefit Plans”), subject to any and all terms, conditions and eligibility
requirements of said benefits or plans, as may be in effect from time to time. 
 (c) Equity Incentive. The parties agree that the
Executive shall be eligible, at the sole discretion of the Board, to receive grants of restricted stock or options to acquire shares of common stock of MAP subject to the terms of the MAP Pharmaceuticals, Inc. 2004 Long–Term Incentive Plan, as
amended (the “Option Plan”). 
 (d) Vacation and Holidays. The Executive shall be entitled to three (3) weeks of
paid vacation per year, provided that the Executive shall take vacation at such times as may be mutually agreed upon by MAP and the Executive. Additionally, the Executive shall be entitled to a minimum of nine (9) days of paid holiday
leave as determined by MAP in accordance with its regular practices. 
 (e) Expense Reimbursement. MAP shall reimburse the Executive
for all reasonable out-of-pocket expenses incurred by the Executive in the performance of his duties under this Agreement. The Executive shall provide MAP with receipts or other records substantiating such expenses as may be reasonably requested by
MAP. 
 (f) Deductions and Withholdings. All amounts payable hereunder shall by subject to deduction and withholding as required by
law. 
 4. Termination. Both MAP and the Executive shall have the right to terminate the Executive’s employment with MAP at any
time, with or without cause, and without prior notice. If the Executive’s employment with MAP is terminated, the Executive will be eligible to receive severance benefits to the extent provided in this Agreement and described more specifically
below. 
  

 2 

 (a) Additionally, the Executive’s employment may be terminated by MAP (and in the case of clause
(i) below, will be automatically terminated) at any time as follows: 
 (i) upon the death of the Executive at any time; 
 (ii) due to the Disability of the Executive upon delivery of a Notice of Termination to the Executive at any time; 
 (iii) for Cause upon delivery of a Notice of Termination to the Executive at any time; 
 (iv) other than due to death, Disability or for Cause, thirty (30) days after delivery of a Notice of Termination to the Executive not within a
ninety (90) day period immediately following a Change in Control; or 
 (v) other than due to death, Disability or for Cause, within
the ninety (90) day period immediately following a Change in Control. 
 (b) Additionally, the Executive may terminate his employment by
MAP at any time as follows: 
 (i) thirty (30) days after the Executive delivers a Notice of Termination to MAP if MAP materially
breaches this Agreement and does not cure the breach within such thirty-day period; 
 (ii) ninety (90) days after the Executive
delivers a Notice of Termination for any reason (other than a material breach of this Agreement by MAP or for Good Reason); 
 (iii) for
“Good Reason,” not within the ninety (90) day period immediately following a Change in Control; or 
 (iv) within the
ninety (90) day period immediately following a Change in Control, only for “Good Reason.” 
 (c) If the
Executive’s employment is terminated (i) by reason of the Executive’s death, (ii) due to the Executive’s Disability, (iii) for Cause, or (iv) by the Executive for any reason other than a material breach of this
Agreement by MAP or the reasons described in 4(b)(iii) or 4(b)(iv) above, the Executive shall have no right to receive any payments or benefits from MAP after the Termination Date, except for (x) the amount of any Accrued Compensation, and
(y) payments or benefits payable pursuant to other agreements, the MAP Benefit Plans, and other plans or programs maintained by MAP, in each case to the extent provided by the terms of such plans and programs in effect immediately prior to the
Termination Date. 
 (d) If the Executive’s employment is terminated (A) by MAP or any successor corporation at any time pursuant
to Sections 4(a)(iv) or 4(a)(v) or (B) by the Executive pursuant to Sections 4(b)(i), (iii) or (iv), the Executive, while living and in lieu of any other rights, 

  

 3 

 
payments or benefits arising out of the Executive’s employment by MAP, (i) shall be entitled to receive the amount of any Accrued Compensation,
(ii) shall be entitled to receive a lump sum amount equal to 100% of one (1) year’s Base Salary at the rate in effect immediately prior to the Termination Date, (iii) shall be entitled to receive any incentive compensation to the
extent payable under the terms of any bonus or incentive plans in effect immediately prior to the Termination Date, and (iv) shall continue to participate in MAP Benefit Plans on the same terms in effect immediately prior to the Termination
Date for the remainder of the then current Term. 
 (e) Upon the Termination Date, in the event the termination of the Executive occurred due
to 4(a)(iv), 4(a)(v), 4(b)(i), 4(b)(iii) or 4(b)(iv), for a period of up to six months as may be requested by the Board (the “Consulting Period”), MAP shall retain the Executive as a consultant and the Executive shall be available
to render such advisory or consulting services in relation to MAP as MAP may reasonably request from time to time, in an amount not to exceed ten (10) hours per month. In consideration for such consulting, the Executive shall receive the
severance benefits described in 4(d), above. 
 (f) Except as otherwise modified by a written agreement between MAP and the Executive, the
severance pay and benefits provided for in this Section 4 shall be in lieu of any other severance pay or benefits which the Executive may be entitled to receive under any severance or termination plan, program, practice or arrangement
maintained by MAP. Payment of any compensation and benefits in accordance with this Section 4 shall be subject to the Executive’s continued compliance with Sections 6, 7, 8, and 9 and to the execution and delivery by the Executive, or by
the Executive’s personal representative in the event of the Executive’s death or Disability, of an agreement in which the Executive or his personal representative agrees to waive any and all claims against MAP except claims for payments
and benefits to be received pursuant to Sections 4(c), (d) or (e) of this Agreement, as applicable. Notwithstanding any provision of this Agreement, in the event that any payment or benefit (within the meaning of Section 280G(b)(2) of
the Internal Revenue Code of 1986, as amended (the “Code”)) to the Executive (or for his benefit) paid or payable pursuant to Section 4(d) above would result in an excise tax under Section 4999 of the Code or would not be
deductible (in whole or in part) as a result of Section 280G of the Code (or any successor provision), then the amount payable to the Executive under Section 4(d) above shall be payable either: 
 (i) in full, or 
 (ii) as to such lesser
amount which would result in no portion of such benefits being subject to excise tax under Section 4999 of the Code, 
 whichever of
the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of benefits under this
Agreement, notwithstanding that all or some portion of such benefits may be subject to the excise tax imposed under Section 4999 of the Code. Unless the Company and the Executive otherwise agree in writing, the determination as to whether any
payment or benefit hereunder will be nondeductible as a result of Section 280G of the Code shall be made by tax counsel selected by MAP’s independent auditor. 
  

 4 

 5. Acknowledgements by the Executive. The Executive acknowledges that, (a) prior to the date
of this Agreement he has received and had access to, and after the date of this Agreement he will continue to receive and have access to, Confidential Information in connection with his employment by MAP; (b) all Confidential Information known
or obtained by the Executive, whether before or after the date of this Agreement, is the property of MAP; (c) the business of MAP is international in scope; (d) MAP’s products and services are marketed throughout the world;
(e) MAP competes with businesses that are or could be located throughout the world, (f) the provisions of Sections 6, 7, 8, and 9 are reasonable and necessary to protect and preserve MAP’s business; (g) MAP would be irreparably
damaged if the Executive were to breach the covenants set forth in Sections 6, 7, 8, or 9; and (h) the parties have entered into this Agreement in good faith and for the reasons set forth in the recitals hereto and assume that this Agreement is
legally binding. 
 6. Nondisclosure of Confidential Information. During the Term or at any time thereafter, the Executive agrees that
he will not disclose, furnish or make accessible to any entity or person, other than MAP or its affiliates or representatives, any Confidential Information, or in any way use any Confidential Information in the conduct of any business without the
prior written consent of MAP. Nothing contained in this Agreement shall be deemed a waiver, modification or limitation of any rights MAP or its affiliates may have under applicable foreign, federal, state or local laws pertaining to the protection
of trade secrets or confidential information. The Executive will promptly return all Confidential Information to MAP upon the termination of the Executive’s employment for whatever reason. 
 7. Noncompetition. During the Term and the Consulting Period, the Executive agrees that he will not directly or indirectly, engage or invest in,
own, manage, operate, finance, control or participate in the ownership, management, operation, financing or control of, be employed by, associated with, or in any manner connected with, lend his name or credit to, or render services or advice to,
any business the products or activities of which directly compete, in whole or in part, with the products or activities of MAP in any state or country in the world. Notwithstanding the foregoing, the Executive may purchase or otherwise acquire up to
(but not more than) one percent (1%) of any class of securities of any enterprise (but without otherwise participating in the activities of such enterprise) if such securities are listed on any national or regional securities exchange or have
been registered under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”). 
 8.
Nonsolicitation. During the Term and the Consulting Period, the Executive will not: 
 (a) directly or indirectly, for himself or any
other person or entity (i) induce or attempt to induce any employee of MAP to leave the employ of MAP, (ii) in any way interfere with the relationship between MAP and any employee of MAP; or (iii) induce or attempt to induce any
customer, supplier, licensee, or business relation of MAP to cease doing business with MAP, or in any way interfere with the relationship between any customer, supplier, licensee or business relation of MAP; or 
 (b) directly or indirectly, either for himself or any other person or entity, solicit the business of any person or entity known to the Executive to be a
customer of MAP whether or not the Executive had personal contact with such person or entity, with respect to the products or activities which compete in whole or in part with the products or activities of MAP. 
  

 5 

 9. Assignment of Intellectual Property. To the extent that the Executive has not already done so
pursuant to the Current Agreement and except to the extent prohibited by agreements with employers prior to Sheffield Pharmaceuticals, Inc., the Executive hereby assigns all of the Intellectual Property conceived, designed, devised, developed,
perfected or made by the Executive prior to the Effective Date. Any Intellectual Property designed, devised, developed, perfected or made by the Executive after the date of this Agreement shall be promptly disclosed to MAP by the Executive and
become the property of MAP, and the Executive hereby assigns, transfers and conveys such Intellectual Property to MAP. The Executive further agrees to make and provide to MAP, at MAP’s expense, any documents, instruments or other materials
necessary or convenient to vest, secure, evidence or maintain MAP’s ownership of the Intellectual Property, and patents, copyrights, trademarks and similar foreign and domestic property rights with respect to the Intellectual Property. Any
Intellectual Property conceived, designed, devised, developed, perfected or made by the Executive within one (1) year after termination of the Executive’s employment with MAP shall be conclusively presumed to have been conceived during the
Executive’s employment with MAP, and the burden of proving otherwise shall rest with the Executive. 
 10. Survival of Covenants.
The covenants by the Executive in Sections 6, 7, 8 and 9 are essential elements of this Agreement. If the Executive’s employment with MAP expires or is terminated, this Agreement will continue in full force and effect as is necessary or
appropriate for MAP to enforce any of the covenants in Sections 6, 7, 8, or 9. 
 11. Enforcement and Arbitration. 
 (a) Within ten (10) days of MAP’s request, the Executive will confirm to MAP in writing the Executive’s compliance with Sections 6, 7, 8 or
9 during the period which such covenants remain in force. 
 (b) Unless otherwise prohibited by law or specified below, all disputes, claims
and causes of action, in law or equity, arising from or relating to this Agreement or its enforcement, performance, breach, or interpretation shall be resolved solely and exclusively by final and binding arbitration held in San Francisco County,
California through Judicial Arbitration & Mediation Services/Endispute (“JAMS”) under the then existing JAMS arbitration rules. However, nothing in this section is intended to prevent either party from obtaining injunctive
relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Each party in any such arbitration shall be responsible for its own attorneys’ fees, costs and necessary disbursement; provided, however,
that if one party refuses to arbitrate and the other party seeks to compel arbitration by court order, if such other party prevails, it shall be entitled to recover reasonable attorneys’ fees, costs and necessary disbursements. Pursuant to
California Civil Code Section 1717, each party warrants that it was represented by counsel in the negotiation and execution of this Agreement, including the attorneys’ fees provision herein. If either party hereto brings any action to
enforce rights hereunder, each party in any such action shall be responsible for its own attorneys’ fees and costs incurred in connection with such action. 
  

 6 

 12. Authority; No Conflict. This Agreement constitutes the legal, valid and binding obligation of
the Executive, enforceable against the Executive in accordance with its terms. The Executive has the unrestricted right, authority and capacity to execute and deliver this Agreement and to perform his obligations under this Agreement. The
Executive’s execution and delivery of this Agreement will not result in a violation or breach of any provision or, or give any person the right to declare a default or exercise any remedy under any contract applicable to the Executive. The
Executive is not required to give any notice or to obtain any consent from any person in connection with the Executive’s execution and delivery of this Agreement. 
 13. Notices. All notices, consents, waivers and other communications under this Agreement must be sent in writing and will be deemed to have been duly given when (a) delivered by hand, (b) sent by
facsimile (with written evidence of receipt), provided that a copy is mailed by registered mail, return receipt requested, or (c) when received by the addressee, if sent by a nationally recognized delivery service, in each case to the
respective addresses last given by each party to the other, provided that all notices to MAP shall be directed to the attention of the board of directors of MAP, with a copy to the Secretary of MAP. 
 14. Successors and Assigns. This Agreement shall be binding and inure to the benefit of the parties hereto and their respective successors and
assigns; provided that the Executive shall be prohibited from assigning any of the Executive’s rights, title or interest in this Agreement. 
 15. Amendment; Waiver. No change or modification of this Agreement shall be valid or binding unless in writing and signed by both parties. No waiver of any provision of this Agreement shall be valid unless in
writing and signed by the party against whom the waiver is sought to be enforced. A valid waiver of any provision of this Agreement shall be limited to the instance specified in such writing and, unless otherwise expressly stated, shall not be
effective as a continuing waiver or repeal of such provision. 
 16. Governing Law. The validity, performance, construction and effect
of this Agreement shall be governed by the substantive laws of the State of California, without regard to the provisions for choice of law thereunder. 
 17. Severability. In the event any provision or portion of this Agreement is held to be illegal, invalid or unenforceable, in whole or in part, for any reason, under present or future law, such provision shall
be severable and the remainder thereof shall not be invalidated or rendered unenforceable or otherwise adversely affected. Without limiting the generality of the foregoing, if a court of competent jurisdiction should deem any provision of this
Agreement to create a restriction that is unreasonable at to its scope, duration or geographical area, the parties agree that the provisions of this Agreement shall be enforceable in such scope, for such duration and in such geographic area as any
court of competent jurisdiction may determine to be reasonable. 
 18. Entire Agreement. This Agreement constitutes the entire
agreement between the parties with respect to the subject matter hereof and supersedes all prior written and oral agreements and understandings between the parties with respect to the subject matter hereof. 
  

 7 

 19. Negotiated Agreement. The Executive acknowledges that he was represented by experienced
counsel in connection with the negotiation of this Agreement, and the parties agree that this Agreement shall be construed as drafted by both of them, as parties of equivalent bargaining power, and not for or against either of them as the drafter.

 20. Claims by the Executive. The existence of any claim or cause of action by the Executive against MAP shall not constitute a
defense to the enforcement by MAP of the Executive’s covenants, obligations or undertakings in this Agreement, including, without limitation, the covenants in Sections 6, 7, 8 and 9. 
 21. Headings. The headings of sections herein are included solely for convenience of reference and shall not control the meaning or interpretation
or any of the provisions of this Agreement. All Section references herein are to Sections of this Agreement unless otherwise specified. 
 22. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument. 
 [Signatures on the following page] 
  

 8 

 IN WITNESS WHEREOF, the Executive has executed, and MAP has caused this Agreement to be executed by its
duly authorized officer, as of the date first above written. 
  

			
	 MAP PHARMACEUTICALS, INC.

		
	 By:
	 	 /s/ Thomas K. Garver

	 Name:
	 	 Thomas K. Garver

	 Its:
	 	 Vice President

	
	 /s/ Thomas A. Armer

	Thomas A. Armer, Ph.D

 APPENDIX A 
 DEFINITIONS 
 “Accrued Compensation” shall mean an amount which shall include all
amounts earned or accrued through the Termination Date but not paid as of the Termination Date, including, without limitation, (i) Base Salary, and (ii) reimbursement for reasonable expenses incurred by the Executive on MAP’s behalf
prior to the Termination Date. 
 “Cause” shall mean any one of the following events: (i) the Executive’s
violation of any material provision of this Agreement, including, without limitation, the Executive’s continuing failure (after reasonable notice) to follow the reasonable instructions of the MAP board of directors or executive committee;
(ii) any intentional or grossly negligent act or omission by the Executive that is reasonably likely to lead to the material injury of MAP or its business, employees, customers or vendors; (iii) the Executive’s material violation of
any federal, state or local law applicable to MAP or its business; (iv) the Executive’s plea of guilty or nolo contendere to, or conviction of, a felony or of a misdemeanor involving moral turpitude; or (v) the Executive’s
failure to comply in any material respect with, after the Executive has received written notice from MAP and been given thirty (30) days in which to cure such failure (if curable), the written employee policies and procedures of MAP.

 “Change in Control” shall mean the occurrence of any one of the following events: 
 (a) an acquisition (other than directly from MAP) of any voting securities of MAP (the “Voting Securities”) by any
“Person” (as the term “Person” is used for purposes of Section 13(d) or 14(d) of the Exchange Act) other than any of MAP’s current stockholders (including, without limitation, the purchasers of MAP’s Series
B Convertible Participating Preferred Stock pursuant to the terms of the Stock Purchase Agreement among MAP and the purchasers thereof (the “Series B Purchase Agreement”) entered into on or about the Effective Date) or any entity
under common control therewith, immediately after which such Person has ‘Beneficial Ownership” (within the meaning of Rule 13d-3 under the Exchange Act) of fifty percent (50%) or more of the combined voting power of MAP’s then
outstanding Voting Securities; provided, however that in determining whether a Change in Control has occurred, Voting Securities which are acquired in a “Non-Control Acquisition” (as hereinafter defined) shall not constitute
an acquisition which would cause a Change in Control. A “Non-Control Acquisition” shall mean any acquisition by (1) an employee benefit plan (or a trust forming a part thereof) maintained by (x) MAP or (y) any
corporation or other Person of which a majority of its voting power or its equity securities or equity interest is owned directly or indirectly by MAP (a “Subsidiary”), (2) MAP or any Subsidiary, or (3) any Person in
connection with a “Non-Control Transaction” (as hereinafter defined); 
 (b) Approval by the stockholders of MAP of: 
 (i) a merger, consolidation or reorganization involving MAP, unless (x) the stockholders of MAP, immediately prior to such merger, consolidation or
reorganization, own, directly or indirectly, immediately following such merger consolidation or reorganization, at least one-half of the combined voting power of the outstanding Voting Securities of the 

 
corporation or entity resulting from such merger, consolidation or reorganization (the “Surviving Corporation”) in substantially the same
proportion as their ownership of the Voting Securities immediately before such merger, consolidation or reorganization, and (y) the individuals who were members of the Incumbent Board immediately prior to the execution of the agreement
providing for the merger, consolidation or reorganization constitute at least one-half of the members of the board of directors of the Surviving Corporation (any transaction described in (x)and (y) being defined as a “Non-Control
Transaction”); 
 (ii) a complete liquidation or dissolution of MAP; or 
 (iii) an agreement for the sale or other disposition of all or substantially all of the assets of MAP to any Person (other than to a Subsidiary).

 Anything herein to the contrary notwithstanding, the consummation of the transactions contemplated by the Series B Purchase Agreement
(including, without limitation, the issuance of the Series B Preferred Stock and the reconstitution of MAP’s board of directors in connection therewith) shall not constitute a Change in Control. 
 “Confidential Information” shall mean, whether embodied in written, electronic, digital or other form, (i) information regarding
MAP customers and suppliers, including but not limited to, customer lists, price lists, market studies, contracts, information, requirements, billing histories, marketing methods, names of contacts, and products or services provided by MAP to such
customers or suppliers; (ii) financial information concerning MAP or its affiliates, including but not limited to, financial statements, balance sheets, profit and loss statements, earnings, commissions and salaries paid to employees, sales
data and projections, cost analyses and similar information; (iii) plans and projections for business opportunities for new or developing business of MAP or its affiliates; (iv) information relating to the trade secrets, product
specifications, know-how, formulae, compositions, processes, designs, inventions, ideas, improvements, and computer software and database technologies of MAP; and (v) any notes, analyses, compilations, studies, summaries or other material
prepared by or for MAP containing or based, in whole or in part, on any information included in the foregoing. In no event will “Confidential Information” include (x) information that is or becomes generally known to and available for
use by the public other than as a result of the Executive’s fault or the fault of any other person or entity bound by a duty of confidentiality to MAP, or (y) information that is required by law to be disclosed by the Executive,
provided that no disclosure shall be made until the Executive has given reasonable written notice to MAP of the anticipated disclosure so that MAP may contest the need for disclosure, and the Executive will cooperate with MAP in connection
with any such contest. 
 “Disability” shall mean a determination that the Executive is unable to substantially perform the
duties and responsibilities contemplated by this Agreement as a result of physical or mental incapacity, which inability continues for a period of 180 consecutive days, as determined by the board of directors of MAP in good faith after receiving
certification or other substantiation of such incapacity from a medical doctor selected by the board of directors. 
 “Good
Reason” shall mean the Executive’s voluntary termination, following (A) a reduction by MAP of Executive’s annual base salary as in effect on the Effective Date except to the extent the annual base salary of all other
executives of MAP are similarly reduced; (b) the 

  

 11 

 
taking of any action by MAP that would adversely affect Executive’s participation in, or reduce Executive’s benefits under, MAP’s benefit
plans (including the Option Plan) as of the Effective Date, except to the extent the benefits of all other executives of MAP are similarly reduced; (c) the assignment to Executive of any duties or responsibilities that results in any diminution
or adverse change of Executive’s position, status, circumstances of employment or scope of responsibilities; provided, however, that if (i) prior to a Change in Control, MAP hires a new Chief Executive Officer
(“CEO”) and Executive is asked to resign as Acting CEO, but the Executive remains the Executive Vice President and Chief Scientific Officer of MAP, or (ii) following a Change in Control, MAP becomes a division of, or a business unit
of another corporation or other business entity and the Executive remains the Executive Vice President and Chief Scientific Officer of the division or business unit comprised of MAP, such changes of the Executive’s responsibilities of
employment which would reflect these circumstances shall not be deemed to be a material diminution which would give rise, in and of itself, to Good Reason; or (d) Executive’s refusal to relocate to a location more than twenty-five
(25) miles from MAP’s location at the Effective Date. 
 “Intellectual Property” means any or all of the following
(including all rights arising out of or associated therewith) which are conceived, designed, devised, developed, perfected or made by the Executive, whether alone or in conjunction with others, and related in any manner to the actual or anticipated
business or research and development of MAP or its affiliates: (i) United States, international or foreign patents and applications therefor, (ii) inventions (whether or not patentable), invention disclosures, improvements, trade secrets,
proprietary information, know-how, technology, technical data and customer lists, product formulations and specifications, and all documentation relating to any of the foregoing throughout the world, (iii) writings, books, works of authorship,
copyrights, copyright registrations and applications therefor, and all other rights corresponding thereto throughout the world; (iv) rights in internet uniform resource locators (URLs), domain names, trade names, logos, slogans, designs, common
law trademarks and service marks, trademark and service mark applications and registrations therefor throughout the world; (v) all databases and data collections and all rights therein throughout the world; and (vi) any similar or
equivalent rights to any of the foregoing throughout the world. The term “Intellectual Property” shall be given the broadest interpretation possible and shall include any Intellectual Property conceived, designed, devised, developed,
perfected or made by the Executive during off-duty hours and away from any premises of MAP and during the regular course of the Executive’s duties as an employee of MAP. 
 “Notice of Termination” shall mean a written notice of termination provided by one party to the other which specifies an effective date
of termination, indicates the specific termination provision in this Agreement relied upon and sets forth in reasonable detail the facts and circumstances claims to provide a basis for termination of the Executive’s employment under the
provision indicated. 
 “Termination Date” shall mean the date on which the Executive’s employment terminates. In the
case of the Executive’s death, the Termination Date shall be the date of the Executive’s death, and in all other cases, the date specified in the Notice of Termination, in accordance with this Agreement. 
  

 12Restricted Stock Agreement dated as of August 12, 2004 - Thomas A. Armer

 EXHIBIT 10.8 
 RESTRICTED STOCK AGREEMENT 
 This RESTRICTED STOCK AGREEMENT (this “Agreement”) is
entered into as of the 12th day of August, 2004 (the “Date of Issuance”), by and between MAP Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Thomas A. Armer, an individual resident in the State of
California (“Employee”). Capitalized terms not defined in this Agreement shall have the meanings ascribed to them in the MAP Pharmaceuticals, Inc. 2004 Long-Term Incentive Plan, as amended (the “Plan”). 

1. Issuance of Shares. The Company hereby awards to Employee 40,960 shares of Common Stock of the Company, which shall be Restricted Stock (the
“Shares”), subject to the terms and conditions of this Agreement and the Plan, in consideration for past services rendered to the Company equal in value to the Fair Market Value (as defined below) of the Shares. 
 2. Fair Market Value of the Shares. The Company and Employee agree that the fair market value per share of the Shares as of the Date of Issuance
is $1.25 per share (the “Fair Market Value”); provided, however, that Employee acknowledges that such determination of the Fair Market Value of the Shares is not binding upon the Internal Revenue Service or any
other governmental authority (a “Governmental Authority”), and that a Government Authority may take the position that the fair market value of the Shares for federal income tax purposes is different from the Fair Market Value
provided in this Section 2. 
 3. Restrictions on Transferability of Shares; Vesting. 
 (a) Restricted Period. For purposes of this Agreement, the term “Restricted Period” shall mean the period commencing on the Date
of Issuance and ending on August 12, 2008. 
 (b) Restrictions. During the Restricted Period, Employee shall not sell, assign,
transfer, exchange, pledge, hypothecate, or otherwise encumber (each a “Transfer”) (i) the Shares with respect to which the restrictions set forth in this Section 3(b) have not lapsed in accordance with
Section 3(d) of this Agreement (the “Restricted Shares”), (ii) the right to vote the Restricted Shares, or (iii) the right to receive dividends on the Restricted Shares (collectively, the
“Restrictions”); provided, however, that Employee shall have all other rights of a stockholder of the Company, including, without limitation, the right to receive dividends on and the right to vote the
Shares. Any attempted Transfer of the Restricted Shares shall be void and without effect. 
 (c) Forfeiture in the Event of
Termination. Subject to Section 7 of this Agreement, in the event of the termination of Employee’s employment with the Company prior to the end of the Restricted Period, all rights to the Restricted Shares which have not
vested in accordance with Section 3(d) of this Agreement at that time shall be forfeited to the Company without consideration. 
 (d) Vesting. The Shares shall vest in forty-eight (48) equal, monthly installments, with the first installment vesting on September 12, 2004, and each additional installment on the twelfth (12th) day of each
consecutive calendar month thereafter (each, a “Vesting Date”) until and ending on August 12, 2008. 
  

 1 

 (e) Termination (Lapse) of the Restrictions. On each Vesting Date, the Restrictions shall lapse
with respect to the number of Shares vesting on that date. Those Shares with respect to which the Restrictions have lapsed are sometimes referred to herein as “Vested Shares.” Vested Shares shall not be subject to forfeiture under
Section 3(c) above. 
 4. Employee’s Representations. By receipt of the Shares and by execution of this
Agreement, Employee represents to the Company that: 
 (a) Employee understands that the Shares are securities, the issuance by the Company
of which requires compliance with federal and state securities laws; 
 (b) Employee understands that the Shares are being issued to
Employee only on the condition that Employee makes the representations contained in this Section 4 to the Company; 
 (c)
Employee has made a reasonable investigation of the business and affairs of the Company sufficient to be well informed as to the rights and the value of the Shares; 
 (d) Employee understands that the Shares have not been registered under the Securities Act of 1933, as amended (the “Act”), in reliance upon one or more specific exemptions contained in the Act, which
may include reliance on Rule 701 promulgated under the Act, if available, or which may depend upon (a) Employee’s bona fide investment intention in acquiring the Shares, (b) Employee’s intention to hold the Shares in compliance
with federal and state securities laws, (c) Employee having no present intention of selling or transferring any part thereof in violation of applicable federal and state securities laws, and (d) there being certain restrictions on transfer
of the Shares; and 
 (e) Employee understands that (a) the Shares, in addition to other restrictions on transfer, must be held
indefinitely unless subsequently registered under the Act, or unless an exemption from registration is available, (b) Rule 144, the usual exemption from registration, is only available after the satisfaction of certain holding periods and in
the presence of a public Market for the Shares, (c) there is no certainty that a public market for the Shares will exist, and (d) it will be necessary that the Shares be sold pursuant to another exemption from registration which may be
difficult to satisfy. 
 5. Certain Tax Matters; Withholding Obligations. 
 (a) Withholding. No later than the earlier of: (i) the date on which the Restrictions lapse with respect to any of the Restricted Shares, or
(ii) the date on which Employee makes an election under Section 83(b) of the Internal Revenue Code of 1986, as amended (the “Code”) in accordance with Section 5(b) of this Agreement, Employee hereby agrees to
pay to the Company, or to make arrangements satisfactory to the Company regarding, any federal, state or local taxes of any kind which may be required to be withheld with respect to the issuance and vesting of the Shares; and the Company shall, to
the extent permitted by law, have the right to deduct and withhold from any payments of any kind otherwise due to Employee any federal, state or local taxes of any kind required by law to be withheld with respect to the issuance and vesting of the
Shares. 

 (b) Section 83(b) Election. Employee may elect, within thirty (30) days of the Date of
Issuance, and upon written notice delivered to the Internal Revenue Service with a copy delivered to the Committee, to recognize income for federal income tax purposes equal to the Fair Market Value of the Shares as of the date the Shares are
transferred to him, regardless of the Restrictions and the vesting schedule in Section 3(d) of this Agreement. In the event Employee makes such an election, he or she shall make arrangements satisfactory to the Company to pay in
the current year any federal, state or local taxes required to be withheld with respect to the issuance and vesting of the Shares. If Employee fails to make such payments to the Company, the Company shall, to the extent permitted by law, have the
right to deduct and withhold in the year of this grant any federal, state or local taxes of any kind required by law to be withheld with respect to the issuance and vesting of the Shares. 
 6. Subject to Agreements. Employee acknowledges and agrees that the Shares shall be subject to the terms and conditions of (a) the
Stockholders Agreement among the Company, Employee and the other stockholders of the Company dated as of March 3, 2004 (as it may be amended or restated from time to time, the “Stockholders Agreement”) and (b) the
Registration Rights Agreement among the Company, Employee and the other stockholders of the Company dated as of March 3, 2004 (as it may be amended or restated from time to time). 
 7. Adjustments; Change of Control. 
 (a) In the event of any change in the outstanding shares of Common Stock that occurs after the Date of Issuance by reason of any stock dividend, stock split, reverse stock split, recapitalization, reclassification, merger, conversion,
consolidation, liquidation, spin-off, reorganization, combination or exchange of shares or other similar corporate change, the number of Shares shall be appropriately adjusted by the Committee, whose determination shall be conclusive and binding.

 (b) If (i) a Change in Control (as defined in Annex A) occurs and (ii) either (A) the Company terminates Employee’s
employment for any reason other than for Cause (as defined in Annex A hereto) within 90 days thereafter or (B) Employee terminates his own employment for Good Reason (as defined in Annex A) within ninety (90) days thereafter, then any
remaining Restrictions shall lapse automatically, without any action on the part of the Company or Employee, and any Restricted Shares shall therefore automatically become Vested Shares. 
 8. Stock Certificates. Each stock certificate for the Shares issued to Employee shall have conspicuously written, printed, typed or stamped upon
the face thereof, or upon the reverse thereof with a conspicuous reference on the face thereof, of the following legend: 
 THIS CERTIFICATE
AND THE SHARES OF STOCK REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS (INCLUDING THE RISKS OF FORFEITURE AND RESTRICTIONS AGAINST TRANSFER) CONTAINED IN THE MAP PHARMACEUTICALS, INC. 2004 LONG TERM 

 
INCENTIVE PLAN, AND AGREEMENTS ENTERED INTO BETWEEN THE REGISTERED OWNER AND MAP PHARMACEUTICALS, INC. RELEASE FROM SUCH TERMS AND CONDITIONS SHALL BE MADE
ONLY IN ACCORDANCE WITH THE PROVISIONS OF THE PLAN AND AGREEMENTS, COPIES OF WHICH ARE ON FILE IN THE OFFICE OF THE SECRETARY OF MAP PHARMACEUTICALS, INC. 
 Employee agrees to deposit any and all stock certificates representing the Restricted Shares to the Company or its designee until such time as the Restrictions shall have lapsed. 
 9. Severability; Construction. In the event that any provision in this Agreement shall be invalid or unenforceable, such provision shall be
severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement. This Agreement shall be construed as to its fair meaning and not for or against either party.

 10. Damages. The parties agree that any violation of this Agreement (other than a default in the payment of money) cannot be
compensated for by damages, and any aggrieved party shall have the right, and is hereby granted the privilege, of obtaining specific performance of this Agreement in any court of competent jurisdiction in the event of any breach hereunder.

 11. Governing Law. This Agreement shall be deemed to be made under and governed by and construed in accordance with the laws of the
State of California, without regard to conflicts of law principles. 
 12. Delay. No delay or failure on the part of the Company or
Employee in the exercise of any right, power or remedy shall operate as a waiver thereof, nor shall any single or partial exercise by any of them of any right, power or remedy preclude other or further exercise thereof, or the exercise of any other
right, power or remedy. 
 13. Market Standoff. Without limiting the generality of the acknowledgement set forth in Section 6
above, the Employee acknowledges that the shares are subject to the Section 5.1 of the Stockholders Agreement (and any successor provision thereto). 
 14. Notices. Any notice required to be given or delivered to the Company under the terms of this Agreement shall be in writing and addressed to the Secretary of the Company at its principal offices. Any notice
required to be given or delivered to Employee shall be in writing and addressed to Employee at the address indicated above or to such other address as such party may designate in writing from time to tome to the Company. All notices shall be deemed
to have been given or delivered upon: personal delivery; three (3) days after deposit in the United States mail by certified or registered mail (return receipt requested); one (1) business day after deposit with any return receipt express
courier (prepaid); or one (1) business day after transmission by facsimile or telecopier. 
 15. Arbitration. Unless otherwise
prohibited by law or specified below, all disputes, claims and causes of action, in law or equity, arising from or relating to this Agreement or its enforcement, performance, breach, or interpretation shall be resolved solely and exclusively by
final and binding arbitration held in San Francisco County, California through Judicial 

 
Arbitration & Mediation Services/Endispute (“JAMS”) under the then existing JAMS arbitration rules. However, nothing in this
section is intended to prevent either party from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Each party in any such arbitration shall be responsible for its own attorneys’
fees, costs and necessary disbursement; provided, however, that if one party refuses to arbitrate and the other party seeks to compel arbitration by court order, if such other party prevails, it shall be entitled to
recover reasonable attorneys’ fees, costs and necessary disbursements. Pursuant to California Civil Code Section 1717, each party warrants that it was represented by counsel in the negotiation and execution of this Agreement, including the
attorneys’ fees provision herein. If either party hereto brings any action to enforce rights hereunder, each party in any such action shall be responsible for its own attorneys’ fees and costs incurred in connection with such action.

 16. Complete Agreement. This Agreement constitutes the entire agreement between the parties with respect to its subject matter, and
supersedes all other prior or contemporaneous agreements and understandings both oral or written; provided, however, that in the event of any conflict between this Agreement and the Plan, the Plan shall govern. This
Agreement may only be amended in a writing signed by the Company and the Employee. 
 [Signature Page Follows] 

 IN WITNESS WHEREOF, the Company and Employee have executed this Agreement as of the date first set forth
above. 
  

			
	MAP PHARMACEUTICALS, INC.
		
	By:	 	 /s/ Thomas K. Garver

	Name:	 	Thomas K. Garver
	Its:	 	Vice President

 EMPLOYEE ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE PLAN WHICH IS INCORPORATED HEREIN
BY REFERENCE, THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT AND THE VESTING SCHEDULE SET FORTH IN THIS AGREEMENT DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS AN EMPLOYEE FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT
ALL, AND SHALL NOT INTERFERE WITH EMPLOYEE’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE EMPLOYEE’S EMPLOYMENT AT ANY TIME, WITH OR WITHOUT CAUSE. 
 Employee acknowledges receipt of a copy of the Plan, represents that Employee is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof.
Employee has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement. Employee hereby agrees to accept as
binding, conclusive and final all decisions or interpretations of the Board or of the Committee upon any questions arising under the Plan. 
  

			
	 /s/ Thomas A. Armer

	 Employee

	 Dated:
	 	 8/12/04

 Annex A 
 “Change in Control” shall mean the occurrence of any one of the following events: 
 (a) an
acquisition (other than directly from the Company) of any voting securities of the Company (the “Voting Securities”) by any “Person” (as the term “Person” is used for purposes of Section 13(d) or 14(d) of
the Exchange Act) other than any of the Company’s current stockholders or any purchaser of Voting Securities in connection with an equity financing in which the Company raises in excess of $15,000,000 that closes within 90 days after the Date
of Issuance (a “Near-Term Investor”), or any entity under common control therewith, immediately after which such Person has “Beneficial Ownership” (within the meaning of Rule 13d-3 under the Exchange Act) of fifty percent
(50%) or more of the combined voting power of the Company’s then outstanding Voting Securities; provided, however that in determining whether a Change in Control has occurred, Voting Securities which are acquired in a “Non-Control
Acquisition” (as hereinafter defined) shall not constitute an acquisition which would cause a Change in Control. A “Non-Control Acquisition” shall mean any acquisition by (1) an employee benefit plan (or a trust forming a
part thereof) maintained by (x) the Company or (y) any corporation or other Person of which a majority of its voting power or its equity securities or equity interest is owned directly or indirectly by the Company (a
“Subsidiary”), (2) the Company or any Subsidiary, or (3) any Person in connection with a “Non-Control Transaction” (as hereinafter defined); 
 (b) Approval by the stockholders of the Company of: 
 (1) a merger, consolidation or reorganization involving the Company, unless (x) the stockholders of the Company, immediately prior to such merger, consolidation or reorganization, own, directly or indirectly, immediately following such
merger consolidation or reorganization, at least one-half of the combined voting power of the outstanding Voting Securities of the corporation or entity resulting from such merger, consolidation or reorganization (the “Surviving
Corporation”) in substantially the same proportion as their ownership of the Voting Securities immediately before such merger, consolidation or reorganization, and (y) the individuals who were members of the incumbent board immediately
prior to the execution of the agreement providing for the merger, consolidation or reorganization constitute at least one-half of the members of the board of directors of the Surviving Corporation (any transaction described in (x) and
(y) being defined as a “Non-Control Transaction”); 
 (2) a complete liquidation or dissolution of the Company; or

 (3) an agreement for the sale or other disposition of all or substantially all of the assets of the Company to any Person (other than to
a Subsidiary). 
 Anything herein to the contrary notwithstanding, the consummation of a sale of Voting Securities to Near-Term Investors and
any reconstitution of the Company’s board of directors in connection therewith shall not constitute a Change in Control. 
 “Good
Reason” shall mean the Employee’s voluntary termination, following (A) a reduction by the Company of Employee’s annual base salary as in effect on the effective date of the Change in 

 
Control, except to the extent the annual base salary of all other executives of the Company are similarly reduced; (b) the taking of any action by the
Company that would adversely affect Employee’s participation in, or reduce Employee’s benefits under, the Company’s benefit plans (including the Plan) as of the effective date of the Change in Control, except to the extent the
benefits of all other executives of the Company are similarly reduced; (c) the assignment to Employee of any duties or responsibilities that results in any diminution or adverse change of Employee’s position, status, circumstances of
employment or scope of responsibilities; provided, however, that if (i) prior to a Change in Control, the Company hires a new Chief Executive Officer (“CEO”) and Employee is asked to resign as President and
acting CEO, but Employee remains the Executive Vice President and Chief Scientific Officer of the Company or (ii) following a Change in Control, the Company becomes a division of, or, a business unit of another corporation or other business
entity and the Employee remains the Chief Scientific Officer of the division or business unit comprised of the Company, such a change of the Employee’s responsibilities of employment which would reflect these circumstances shall not be deemed
to be a material diminution which would give rise, in and of itself, to Good Reason; or (D) Employee’s refusal to relocate to a location more than twenty-five (25) miles from the Company’s location immediately prior to the Change
in Control. 
 “Cause” shall mean any one of the following events: (i) the Employee’s continuing failure (after reasonable notice)
to follow the reasonable instructions of the MAP board of directors or executive committee in connection with his employment; (ii) any intentional or grossly negligent act or omission by the Employee that is reasonably likely to lead to the
material injury of MAP or its business, employees, customers or vendors; (iii) the Employee’s material violation of any federal, state or local law applicable to MAP or its business; (iv) the Employee’s plea of guilty or nolo
contendere to, or conviction of, a felony or of a misdemeanor involving moral turpitude; or (v) the Employee’s failure to comply in any material respect with, after the Employee has received written notice from MAP and been given thirty
(30) days in which to cure such failure (if curable), the written employee policies and procedures of MAP.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]